Pitcairn CO Haemonetics Corp Transaction History

Pitcairn CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$75.65 - $93.58 $285,200 - $352,796	-3,770 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$84.96 - $118.91 $35,513 - $49,704	418 Added 12.47%	3,770 $338,000
Q1 2020 May 13, 2020	BUY	$74.34 - $121.82 $249,187 - $408,340	3,352 New	3,352 $334,000
Q2 2018 Aug 02, 2018	SELL	$71.53 - $95.75 $280,397 - $375,340	-3,920 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$60.72 - $74.41 $130,001 - $159,311	-2,141 Reduced 35.32%	3,920 $287,000
Q4 2017 Feb 13, 2018	SELL	$44.96 - $58.99 $1,393 - $1,828	-31 Reduced 0.51%	6,061 $352,000
Q3 2017 Nov 03, 2017	BUY	$40.38 - $44.87 $245,994 - $273,348	6,092	6,092 $274,000

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.